Showing results (141-150 of 65,932) with videos related to

Sort By:
Pageof 6,594
Expert Review of Respiratory Medicine|October 21, 2020
Advances in understanding of mechanisms related to increased cardiovascular risk in COPDPaola Rogliani, Beatrice Ludovica Ritondo, Rossella Laitano, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 24, 2022
Beyond Dual Bronchodilation - Triple Therapy, When and WhyMario Cazzola, Paola Rogliani, Rossella Laitano, et al.
Expert Review of Clinical Pharmacology|May 7, 2021
Classes of drugs that target the cellular components of inflammation under clinical development for COPDMaria Gabriella Matera, Luigino Calzetta, Rosa Annibale, et al.
Pharmacological Reviews|July 15, 2024
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical ApplicationLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Expert Opinion on Drug Delivery|September 16, 2023
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseasesMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Drugs|March 28, 2026
Current and Emerging Biologic Therapies for Severe AsthmaMario Cazzola, Maria Gabriella Matera, Josuel Ora, et al.
Respiratory Medicine|January 23, 2025
Challenges in treating patients with comorbid asthma and bronchiectasisMario Cazzola, Luigino Calzetta, Maria Gabriella Matera, et al.
Respiratory Medicine|November 3, 2024
β-Blockers and Asthma: Surprising findings from the FAERS databaseMario Cazzola, Josuel Ora, Luigino Calzetta, et al.
Respiratory Medicine|October 10, 2021
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic reviewPaola Rogliani, Beatrice Ludovica Ritondo, Ermanno Puxeddu, et al.
Expert Review of Clinical Pharmacology|April 27, 2022
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPDMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Pageof 6,594